Capsaicin

辣椒碱

Report date: 2026/05/15 20:01:45
NME

Base Information

Drug NameCapsaicin
Drug Alias Name(E)-Capsaicin辣椒素卡赛辛CapsaicinumCapsaicina +[23] 
ClassificationSmall molecules
Mechanisms of ActionVanilloid receptor agonists
TargetsTransient receptor potential cation channel subfamily V member 1
Therapy Area/IndicationsDiabetic peripheral neuropathyCough Hypersensitivity SyndromeIschemic Stroke +[32] 
Global Approved IndicationsPainNeuralgia, PostherpeticNeuralgia
Approved Indications in ChinaPainNeuralgia
Original Approved Country/TerritoryMainland China
Original Approved Date2003/01/24
Country/TerritoryCzechiaBelgiumCanada +[19] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNeurogesx Pharma
China Registration ClassN/A

Develop Information

Active CompaniesGrünenthal GmbHGrunenthal GmbhInstituto Mexicano Del Seguro Social +[10] 
Inactive CompaniesNeurogesxAlgorx Pharmaceuticals IncWake Forest University Health Sciences +[21] 
Active IndicationsIschemic StrokePainNeuralgia, Postherpetic +[8] 
Inactive IndicationsDiabetic peripheral neuropathyCough Hypersensitivity SyndromeRadiation Injuries +[24] 

Other Information

ATC CodeM02AB01N01BX04
Related LinksDrugBankKEGG